期刊文献+

人B7-1基因与GPI信号肽序列融和基因的原核表达载体的构建及表达 被引量:1

Construction and expression of procaryotic expression vector of a chimeric GPI-B7-1 cDNA
原文传递
导出
摘要 目的构建GP1锚定蛋白基因与B7—1分子融合的原核高效表达载体(GPI—B7—1),观察融合蛋白的抗肿瘤效应。方法分别从新鲜胎盘和ConA刺激的外周血单核细胞中克隆人胎盘碱性磷酸酶(hPLAP-1)C末端信号肽序列(GPI)和CD80(B7—1)基因。利用PCR技术将GPI和B7—1胞外编码区基因进行融合,并将融合基因亚克隆入原核表达载体(pET-30a)中。重组载体pET-30a—GPI—B7—1转化表达菌株E.coli BL,纯化GPI—B7—1融合蛋白,SDS—PAGE、Western blot分析鉴定其免疫活性。结果PCR和RT—PCR产物经电泳鉴定,在100~250bp处可见到133bp的GPI目的条带。在750bp左右可见到792bp的B7-1胞外编码区基因目的条带。重组载体pET-30a—GPI-B7—1经PCR检测获得900bp左右的目的片段,经EcoRI、Sall双酶切鉴定,得到5000bp和900bp左右大小2个片段,实现了融合蛋白(GPI—B7—1)在大肠杆菌中的高效表达,在非变性条件下纯化该融合蛋白,SDS—PAGE分析显示,表达蛋白的分子量约为38kDa,Western blotting证实38kDa处出现一条特异的显色带,该融合蛋白即为目的蛋白。结论GPI—B7—1表达载体可在大肠杆菌中高效表达获取融合蛋白,为肿瘤免疫治疗奠定了基础。 Objective Through constructing prokaryotic expression vector pET-30a-GPI-B7-1, to gain purified GPI-B7-1 fusion protein so as to confirm the tumor immune effect. Methods The DNA fragment encoding the signal for GPI-anehor attachment of hPLAP-1 and the eDNA encoding the human eostimulatory molecule CD80 ( B7-1 ) were cloned from fresh placenta and human peripheral blood monocytes (PBMC) respectively. The two fragment were annealed to form a fusion gene (GPI-B7-1) by PCR. Then the fusion gene was inserted into the prokaryotic expression vector pET-30a, resulting in pET-30a-GPI-BT-1. Transfer to E. coli BL21, purified fusion protein were analysed by SDS-PAGE and Western blot. Results Agarose gel electrophoresis map of GPI and B7-1 PCR products show that GPI goal gene strap was seen at 133bp region and B7-1 goal gene strap at 792 region. Identification of recombinant pET-30a-GPI-B7- 1 by restriction enzyme and PCR illustrate two goal fragment for 5000 bp and 900 bp, to realize the expression of fusion gene ( GPI-B7-1 ) at the E. coli BL21. The fusion protein was successfully produced in the pET expression system induced by IPTG and purified by Ni2 + -NTA agarose column. By SDS-PAGE and Western blot analysis, the observed molecular weight of the fusion protein was 38 kDa. Conclusion The purified GPI-B7-1 fusion protein can be obtained from E. cofi BL21 transfered by prokaryotic expression vector pET-30a-GPI-B7-1, which will prove useful tool for the study of tumor immune therapy.
出处 《中华普通外科杂志》 CSCD 北大核心 2009年第1期38-41,共4页 Chinese Journal of General Surgery
基金 浙江省科技计划重点科研基金资助项目(2005C23001) 浙江省医药卫生科技计划基金资助项目(2005A048)
关键词 基因表达 糖基磷脂酰肌醇类 免疫疗法 肿瘤学 Gene expression Glyeosylphos phatidylinositols
  • 相关文献

参考文献6

二级参考文献49

  • 1潘玉先,廖志勇,郝卫,车小燕.氯霉素乙酰基转移酶融合蛋白表达、纯化和鉴定[J].免疫学杂志,2004,20(z1):163-164. 被引量:1
  • 2郑一敏,皮国华,谷淑燕.Epstein─Barr病毒膜抗原在中国仓鼠卵巢(CHO)细胞中的表达[J].病毒学报,1995,11(2):107-113. 被引量:11
  • 3Poloso N, Nagarajan S, Bumgarner GW, et al. Designer cancer vaccines made easy: protein transfer of immunostinmlatory molecules for use in therapeutic tumor vaccines[J].Front Biosci, 2001,6: D760- D775.
  • 4Weber MC, Groger RK, Tykocinski ML. A glycosylphosphatidyhnositol -anchored cytokine can function as an artificial cellular adhesin[J]. Exp Cell Res, 1994 , 210( 1 ) :107 - 112.
  • 5Poloso NS, Nagarajan GW, Bumgamer P, et al. Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunositimulatory molecules [ J ]. Vaccine, 2001,19(15-16) : 2 029 - 2 038.
  • 6Nagarajan S, Selvaraj P. Glycolipid - anchored IL- 1 2 expressed on tumor cell surface induces antitumor immune response[J]. Cancer Res, 2002 , 62(10) :2 869-2 874.
  • 7Ikezawa H. Glycosyl-phosphatidylinositol (GPI)-anchoredproteins[J]. Biol Pharm Bull, 2002 , 25(4) :409 - 417.
  • 8Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins[ J]. FASEB J, 1996,10(5) :574 - 586.
  • 9Brodbeck WG , Liu D , Sperry J , et al . localization of classical and alternative pathway regulatory activity within the decayaccelerating factor[J]. J Immunol, 1996,156(7) :2 528 - 2 533.
  • 10McHugh RS, Ahmed SN, Wang YC, et al. Construction,purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80) [J]. Proc Nail Acad Sci USA, 1995 ,92(17) :8 059 - 8 063.

共引文献9

同被引文献5

  • 1Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins. FASEB J, 1996,10:574-586.
  • 2Sun Y, Chen T, Xu Q. Si-Ni-San, a traditional Chinese prescription, and its drug-pairs suppress contact sensitivity in mice via inhibition of the activity of metalloproteinases and adhesion of T lymphocytes. J Pharm Pharmacol,2003,55:839-846.
  • 3Hayakawa M, Kawaguchi S, Ishii S, et al. B7-1-transfected tumor vaccine counteracts chemotherapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells. Int J Cancer, 1997,71 : 1091-1102.
  • 4Yang S, Darrow TL, Seigler HF. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphoeytes by B7 gene-modified melanoma cells. Cancer Res, 1997,57 : 1561-1568.
  • 5Ikezawa H. Glycosyl-phosphatidylinositol ( GPI ) -anchored-proteins. Biol Pharm Bull,2002,25:409-417.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部